|
|
PKA Inhibitor Fragment (6-22) amide TFA
|
EY-01Y12193
|
|
>96.00%
|
5 mg、10 mg
|
￥0.0
|
|
|
|
PAR-3 (1-6) amide (human)
|
EY-01Y12232
|
1872435-09-0
|
>98.00%
|
5mg、25mg
|
￥0.0
|
|
|
|
PACAP-Related Peptide (PRP), human
|
EY-01Y11931
|
|
>98.00%
|
500μg、1mg、5mg
|
￥0.0
|
|
|
|
Osteogenic Growth Peptide, OGP
|
EY-01Y11949
|
132996-61-3
|
>98.00%
|
1mg、5mg、10mg
|
￥0.0
|
|
|
|
Osteogenic Growth Peptide (10-14)
|
EY-01Y11880
|
105250-85-9
|
>98.00%
|
1mg、5mg
|
￥0.0
|
|
|
|
Orexin A (human, rat, mouse) (TFA)
|
EY-01Y12240
|
|
>98.00%
|
1mg、5mg、10mg、50mg
|
￥0.0
|
|
|
|
O-Desmethyl Mebeverine alcohol hydrochloride
|
EY-01Y11815
|
856620-39-8
|
>98.00%
|
2 mg、5 mg、10 mg、50 mg
|
￥0.0
|
|
|
|
Nonapeptide-1 acetate salt
|
EY-01Y12201
|
|
>98.00%
|
1mg、5mg、10mg、50mg、100mg
|
￥0.0
|
|
|
|
Neuropeptide Y (human) (TFA)
|
EY-01Y12208
|
|
>95.00%
|
1 mg、5 mg
|
￥0.0
|
|
